THIORIDAZINE: An Overview of a Phenothiazine Antipsychotic Thioridazine, historically marketed under the widely recognized brand name Mellaril, is a first-generation or typical antipsychotic medication belonging to the phenothiazine antipsychotic chemical class. Introduced during the mid-20th century, this compound represented a milestone in clinical psychiatry, offering a potent pharmacological means to manage severe, debilitating psychiatric conditions. […]
Introduction to Benztropine and Its Pharmacological Classification Benztropine, widely recognized by its brand name Cogentin®, represents a critical pharmacological intervention in the field of neurology and psychiatry. It is classified as a synthetic anticholinergic medication, specifically designed to mitigate the debilitating symptoms associated with Parkinson’s disease and various other movement disorders characterized by muscle rigidity, […]
Introduction and Definition Tardive Dyskinesia, commonly abbreviated as TD, is a debilitating neurological syndrome characterized by involuntary, repetitive, and often purposeless movements. This disorder is classified as a severe extrapyramidal side effect resulting from the chronic use of dopamine receptor blocking agents (DRBAs), most notably the antipsychotic medications prescribed for various psychiatric conditions. The definition […]
Tardive Dyskinesia: An Encyclopedia Entry The Core Definition and Clinical Characteristics Tardive dyskinesia (TD) is a serious and potentially irreversible neurological disorder characterized by involuntary, repetitive movements, primarily affecting the face, mouth, tongue, trunk, and extremities. The term “tardive” signifies delayed onset, highlighting the fact that this condition typically emerges after months or, more commonly, […]